Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

IGC Pharma (IGC) Return on Invested Capital (2016 - 2019)

IGC Pharma has reported Return on Invested Capital over the past 9 years, most recently at 0.0% for Q4 2019.

  • Quarterly Return on Invested Capital changed N/A to 0.0% in Q4 2019 from the year-ago period, while the trailing twelve-month figure was 0.0% through Dec 2019, changed N/A year-over-year, with the annual reading at 0.0% for FY2019, N/A changed from the prior year.
  • Return on Invested Capital was 0.0% for Q4 2019 at IGC Pharma, down from 0.0% in the prior quarter.
  • Over five years, Return on Invested Capital peaked at 0.0% in Q2 2018 and troughed at 0.0% in Q2 2017.
  • The 5-year median for Return on Invested Capital is 0.0% (2015), against an average of 0.0%.
  • The largest YoY upside for Return on Invested Capital was 0bps in 2015 against a maximum downside of 0bps in 2015.
  • A 5-year view of Return on Invested Capital shows it stood at 0.0% in 2015, then tumbled by -354bps to 0.0% in 2016, then increased by 10bps to 0.0% in 2017, then soared by 122bps to 0.0% in 2018, then crashed by -432bps to 0.0% in 2019.
  • Per Business Quant, the three most recent readings for IGC's Return on Invested Capital are 0.0% (Q4 2019), 0.0% (Q3 2019), and 0.0% (Q2 2019).